학술논문

Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Document Type
article
Source
PLOS ONE. 5(6)
Subject
Cystic Fibrosis
Infectious Diseases
Lung
Clinical Research
Rare Diseases
Pediatric Research Initiative
Congenital
Adolescent
Adult
Age Distribution
Aged
Base Sequence
Child
Child
Preschool
Cystic Fibrosis Transmembrane Conductance Regulator
DNA Primers
Humans
Infant
Middle Aged
Mutation
Oligonucleotide Array Sequence Analysis
Polymerase Chain Reaction
General Science & Technology
Language
Abstract
Bacterial communities in the airways of cystic fibrosis (CF) patients are, as in other ecological niches, influenced by autogenic and allogenic factors. However, our understanding of microbial colonization in younger versus older CF airways and the association with pulmonary function is rudimentary at best. Using a phylogenetic microarray, we examine the airway microbiota in age stratified CF patients ranging from neonates (9 months) to adults (72 years). From a cohort of clinically stable patients, we demonstrate that older CF patients who exhibit poorer pulmonary function possess more uneven, phylogenetically-clustered airway communities, compared to younger patients. Using longitudinal samples collected form a subset of these patients a pattern of initial bacterial community diversification was observed in younger patients compared with a progressive loss of diversity over time in older patients. We describe in detail the distinct bacterial community profiles associated with young and old CF patients with a particular focus on the differences between respective "early" and "late" colonizing organisms. Finally we assess the influence of Cystic Fibrosis Transmembrane Regulator (CFTR) mutation on bacterial abundance and identify genotype-specific communities involving members of the Pseudomonadaceae, Xanthomonadaceae, Moraxellaceae and Enterobacteriaceae amongst others. Data presented here provides insights into the CF airway microbiota, including initial diversification events in younger patients and establishment of specialized communities of pathogens associated with poor pulmonary function in older patient populations.